XORTX Therapeutics Inc. (XRTX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -494.42K | -712.95K | -620.87K | -793.52K | -643.73K | -886.41K | -751.85K | -736.54K | -1.3M | -1.3M | -1.07M | -1.73M | -2.49M | -5.16M | -1.24M | -2.4M | -3.17M | -3.95M | -77.25K | -861.99K |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 23.2% | 19.57% | 17.42% | -7.74% | 50.63% | 31.71% | 29.78% | 57.44% | 47.54% | 74.83% | 13.72% | 27.91% | 21.6% | -30.43% | -1506.4% | -178.48% | -171.02% | -444.74% | 35.43% | -344.41% |
| Net Income | -797.27K | -599.54K | -642.27K | -717.7K | -698.67K | 122.53K | -587.01K | 170.07K | -3.02M | 2.7M | -1.33M | -1.69M | -1.83M | -2.92M | -1.56M | -1.58M | -3.38M | 9.09M | -8.35M | -218.45K |
| Depreciation & Amortization | 25.49K | 29.56K | 29.06K | 27.63K | 25.98K | 26.14K | 25.95K | 33.05K | 43.33K | 24.36K | 22.09K | 43K | 66.85K | 21.8K | 28.79K | 12.45K | 4.78K | 4.74K | 4.53K | 4.37K |
| Stock-Based Compensation | 0 | 0 | 0 | 6.95K | 8.97K | 9.51K | 15.86K | 44.03K | 71.97K | 28.82K | 29.68K | 40.76K | 39.55K | 73.92K | 26.61K | 428.55K | 85.11K | 112.66K | 62.22K | 90.45K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14.36K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -6.04K | -89.29K | -61.29K | -176.2K | -246.95K | -772.4K | -263.32K | -1.64M | 1.93M | -3.64M | -11.29K | -26.93K | 0 | -2.11M | -1.09M | -1.78M | -293.47K | -12.19M | 7.99M | -664.86K |
| Working Capital Changes | 283.4K | -53.69K | 53.63K | 65.81K | 266.94K | -272.19K | 56.67K | 659.18K | -326.87K | -412.21K | 222.17K | -95.51K | -745.19K | -224.64K | 1.35M | 520.75K | 413.73K | -976.6K | 225.49K | -73.51K |
| Change in Receivables | 15.32K | -59.09K | -11.33K | 6.39K | 385 | -4.53K | 9.7K | 8.08K | 29.83K | 7.53K | -37.83K | 7.96K | 45.33K | -24.18K | 180.05K | -93.59K | -104.23K | 46.59K | 0 | 25.67K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -7.8K | -268.86K | -5.31K | -21.82K | -3.38K | -4.04K | -23.18K | -12.37K | -2.62K | -9.79K | -7.3K | -9.54K | -19.73K | -21.68K | -7.26K | -27.73K | -3.34K | -17.03K | -12.32K | -10.28K |
| Capital Expenditures | -3.73K | -24.94K | -5.31K | -21.82K | -3.38K | -4.04K | -23.18K | -9.08K | -2.62K | -1 | -7.3K | -1.64K | -2.67K | -4.69K | 633 | -27.73K | -3.34K | -17.03K | -12.32K | -8.29K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -4.07K | -243.93K | 0 | 0 | 0 | 0 | 0 | -3.28K | 0 | -9.79K | 0 | -7.9K | -17.06K | -16.99K | -7.9K | 0 | 0 | 0 | 0 | -1.99K |
| Cash from Financing | -102.75K | 643.14K | 773.74K | -43.44K | 67.58K | 1.11M | -22.24K | -8.86K | 1.7M | -312.25K | -22.43K | -10.14K | -21.98K | 7.07M | -460.78K | -6.19K | 0 | 17.5M | -61.33K | 82.08K |
| Debt Issued (Net) | 0 | 0 | 0 | -23.26K | -23.12K | -22.68K | -22.24K | -8.86K | -15.95K | 0 | 0 | -16.35K | -16.06K | -19.58K | -12.23K | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | -80.83K | 665.29K | 770.6K | 0 | 113.55K | 1.5M | 0 | 0 | 2M | 0 | 0 | 0 | 0 | 5.05M | 0 | 0 | 0 | 16.88M | 0 | 87.45K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -21.92K | -22.15K | 3.15K | -20.18K | -22.85K | -370.27K | 0 | 0 | -281.04K | -312.25K | -22.43K | 6.21K | -5.91K | 2.04M | -448.55K | -6.19K | 0 | 621.41K | -61.33K | -5.37K |
| Net Change in Cash | -611.84K | -346.75K | 126.91K | -831.76K | -578.41K | 172.9K | -777.73K | -756.97K | 387.77K | -1.62M | -1.09M | -1.74M | -2.53M | 1.97M | -1.26M | -2.09M | -2.46M | 13.85M | -150.91K | -895.23K |
| Free Cash Flow | 0 | -712.95K | -620.87K | -815.34K | -647.12K | -890.44K | -775.03K | -745.62K | -1.31M | -1.31M | -1.08M | -1.74M | -2.5M | -5.18M | -1.25M | -2.43M | -3.17M | -3.97M | -89.58K | -872.26K |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 100% | 19.93% | 19.89% | -9.35% | 50.47% | 31.92% | 28.11% | 57.15% | 47.84% | 74.74% | 13.64% | 28.34% | 21.06% | -30.42% | -1293.53% | -178.38% | -171.26% | -353.15% | 27.93% | -341.5% |
| FCF per Share | - | -2.72 | -3.20 | -5.38 | -4.33 | -6.73 | -6.67 | -6.42 | -13.45 | -16.36 | -13.48 | -21.76 | -32.46 | -81.43 | -21.62 | -42.06 | -54.97 | -72.46 | -2.14 | -20.93 |
| FCF Conversion (FCF/Net Income) | 0.62x | 1.21x | 0.96x | 1.11x | 0.92x | -7.23x | 1.28x | -4.33x | 0.43x | -0.48x | 0.80x | 1.02x | 1.36x | 1.77x | 1.04x | 1.94x | 1.17x | -0.43x | 0.01x | 3.95x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |